Dr. Scott Palmer to Serve as AAEP On Call Veterinarian for Preakness Weekend Telecasts
Scott Palmer, VMD, will assist NBC Sports with horse health info... More »
Dr. Mary Scollay to Step in as AAEP On Call Veterinarian for Oaks, Derby
Longtime AAEP On Call Veterinarian Mary Scollay will serve as the spokesperson for equine health during NBCSports racing coverag... More »
Statement from the AAEP regarding the Injury to On Call Veterinarian Dr. Larry Bramlage
Dr. Larry Bramlage injured his head Thursday afternoon in a fall from a golf cart in the barn area of Churchill Downs. He was tr... More »
Summer Education Meetings to Provide New Knowledge to Practitioners of All Experience Levels
The American Association of Equine Practitioners’ 2013 series of summer continuing education meetings will impart the latest tre... More »
AAEP, AVMA Urge Passage of Legislation to End Abusive Soring of Horses
(Lexington, Ky.) - The American Veterinary Medical Association a... More »
AAEP, American Horse Council Partnering to Develop National Equine Health Plan
An Open Letter to the Horse Industry: Time to be Proactive on Eq... More »
Rotavirus, a non-enveloped RNA virus, is a major infectious cause of foal diarrhea and has been documented to cause 50% or more of foal diarrhea cases in some areas.
While rotavirus diarrhea morbidity can be high (50% of susceptible foals), mortality is low (<1%) with veterinary intervention.
Equine rotavirus is transmitted via the fecal-oral route and damages the small intestinal villi resulting in cellular destruction, maldigestion, malabsorption, and diarrhea.
As many as 70% of all foals in the United States will have at least one diarrheal episode prior to weaning. Mare owners need to be aware that strict biosecurity and disinfection during the foaling season also mitigates the morbidity associated with most types of infectious foal diarrheas and other contagious diseases.
Vaccination of mares results in a significant increase in foals’ rotavirus antibody titers. Field trials of rotavirus vaccination in pregnant mares have shown a decrease in incidence and severity of foal diarrhea on farms that historically had annual rotaviral diarrhea cases. Other studies have shown increased rotavirus antibody in vaccinated mares’ colostrum.
The only available vaccine contains inactivated rotavirus Group A and is indicated for administration to pregnant mares to enhance concentrations of colostral immunoglobulins against equine rotavirus (Group A). The vaccine has been used in mares since 1996 in the USA and is considered to be safe.
Pregnant mares (regardless of vaccination history): Should receive a 3-dose series of intramuscular vaccinations at 8, 9, and 10 months of gestation.
Concentrated horse breeding areas in the US routinely use rotavirus vaccine in pregnant mares. Pregnant mares that will be shipped to regions that have had a history of rotaviral diarrhea should also be considered candidates for vaccination.
**It is essential that the newborn foal receives an adequate amount of colostrum and absorbs sufficient anti-rotavirus antibodies from rotavirus-vaccinated mares.
Newborn foals: There are no data to suggest that vaccination of the newborn foal with inactivated rotavirus A vaccine has any benefit for preventing or reducing the severity of infection.
As colostral-derived antibody titers wane at approximately 60 days of age, foals may develop rotaviral diarrhea. However, the severity of diarrhea is generally milder and of shorter duration than foals that become ill within the first 30 days of life.
Other adult horses: Vaccination is unnecessary
©Copyright AAEP 2012
American Association of Equine Practitioners